The higher dose may allow Wegovy to compete with Zepbound more closely, which achieved weight loss of 19.5% and 20.9% with its higher doses of 10 mg and 15 mg, respectively, at 72 weeks
Management of endocrine disease: Are all GLP-1 agonists equal in the treatment of type 2 diabetes
Homocysteine, vitamin B12, and folate circulating levels in women with and without polycystic ovary syndrome: a systematic review and meta-analysis
Common side effects include fatigue, nausea, insomnia, dehydration, and digestive problems
Drugs adopting this strategy produced body weight reduction more than 20%
Those prioritizing longevity and general anti-aging benefits over aggressive tissue repair may find this sufficient